Compare CAG & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAG | BIO |
|---|---|---|
| Founded | 1919 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 8.7B |
| IPO Year | N/A | N/A |
| Metric | CAG | BIO |
|---|---|---|
| Price | $17.50 | $304.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $19.43 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 11.7M | 189.5K |
| Earning Date | 12-19-2025 | 02-12-2026 |
| Dividend Yield | ★ 8.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,234,500,000.00 | $2,557,500,000.00 |
| Revenue This Year | N/A | $1.62 |
| Revenue Next Year | N/A | $2.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.96 | $211.43 |
| 52 Week High | $28.52 | $373.69 |
| Indicator | CAG | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 40.79 |
| Support Level | $16.89 | $306.52 |
| Resistance Level | $17.39 | $316.63 |
| Average True Range (ATR) | 0.46 | 9.57 |
| MACD | 0.08 | -1.13 |
| Stochastic Oscillator | 90.00 | 14.79 |
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.